Sulindac
Term · Oncology and biomedicine · MLC-T-ONC-008380
A nonsteroidal anti-inflammatory drug (NSAID) that is being studied as a treatment for cancer.
A sulfinylindene derivative prodrug with potential antineoplastic activity. Converted in vivo to an active metabolite, sulindac, a nonsteroidal anti-inflammatory drug (NSAID), blocks cyclic guanosine monophosphate-phosphodiesterase (cGMP-PDE), an enzyme that inhibits the normal apoptosis signal pathway; this inhibition permits the apoptotic signal pathway to proceed unopposed, resulting in apoptotic cell death.
| Identifier | MLC-T-ONC-008380 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | SULIN |
| Synonyms | Sulindac Sulfoxide |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-008380",
"term": "Sulindac",
"field": "Oncology and biomedicine",
"definitions": [
"A nonsteroidal anti-inflammatory drug (NSAID) that is being studied as a treatment for cancer.",
"A sulfinylindene derivative prodrug with potential antineoplastic activity. Converted in vivo to an active metabolite, sulindac, a nonsteroidal anti-inflammatory drug (NSAID), blocks cyclic guanosine monophosphate-phosphodiesterase (cGMP-PDE), an enzyme that inhibits the normal apoptosis signal pathway; this inhibition permits the apoptotic signal pathway to proceed unopposed, resulting in apoptotic cell death."
],
"abbreviation": "SULIN",
"synonyms": [
"Sulindac Sulfoxide"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/sulindac/"
}
Record 15,776 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.